Efficacy and Safety of Biosimilar CT-P10 vs Reference Rituximab in Rheumatoid Arthritis - Rheumatology Advisor

Efficacy and Safety of Biosimilar CT-P10 vs Reference Rituximab in Rheumatoid Arthritis  Rheumatology Advisor

Investigators examined the long-term clinical outcomes of extended treatment with biosimilar CT-P10 and 2 approved rituximab reference products in patients ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases